Chapter
Non-RBC Components Produced
4. BLOOD TRANSFUSED IN THE UNITED STATES
Whole Blood and Red Blood Cells Transfused
Non-RBC Components Transfused
Total Components Transfused
5. COMPONENT MODIFICATION
Transfusion of Modified Components
6. CURRENT ISSUES IN BLOOD COLLECTION AND SCREE
7. CURRENT ISSUES IN BLOOD TRANSFUSION
Whole-Blood-Derived Platelets
Blood Collection and Utilization Survey
Cellular Therapy Questionnaire
Characterization of Respondents
Limitations of the Survey
Chapter 2 NATIONAL CORD BLOOD INVENTORY: PRACTICES FOR INCREASING AVAILABILITY FOR TRANSPLANTS AND RELATED CHALLENGES
Cord Blood Banking for the NCBI
HRSA Pilot Project for Remote Collections
HRSA Contracts with Cord Blood Banks
Advisory Council on Blood Stem Cell Transplantation
The Food and Drug Administration’s Regulation of Cord Blood
BANKS REPORTED A NUMBER OF PRACTICES AND CHALLENGES RELATED TO INCREASING UNITS BANKED
Banks Reported Practices That Could Increase Collections at Existing Sites, but Increased Expenditures and Other Factors Could Present Challenges
Expanding the Number of Collection Sites Could Increase the Size and the Diversity of the NCBI, but Banks Reported Challenges Funding New Sites
Banks Reported Additional Practices for Increasing the Genetic Diversity of the NCBI, but Characteristics Associated with Some Units Pose Challenges
Remote Collection Is under Consideration for Increasing Cord Blood Units in the NCBI
Increase in Demand of U.S. Cord Blood Units Has Slowed and Could Challenge Banks’ Efforts to Increase the NCBI
MOST BANKS HAVE ADOPTED PRACTICES TO REDUCE COSTS, BUT ARE UNCERTAIN ABOUT THE EFFECT OF REGULATIONS ON COSTS AND REVENUES
Banks Reported Practices to Lower Costs, but Also Concerns that One Practice Could Adversely Affect the Genetic Diversity of the NCBI
Some Banks Reported Uncertainty about the Effect of Complying with FDA Licensure Regulations on Costs and Revenues
APPENDIX I. COMMENTS FROM THE DEPARTMENT OF HEALTH AND HUMAN SERVICES